US Broker Ratings

Keros Therapeutics, Inc. (KROS) Stock Analysis: A Biotech Player with Over 100% Potential Upside

Keros Therapeutics, Inc. (NASDAQ: KROS), a clinical-stage biopharmaceutical company, is capturing investor attention with its significant growth potential and a promising pipeline of innovative therapeutics. Based..

Zevra Therapeutics, Inc. (ZVRA) Stock Analysis: Exploring a 131.74% Upside Potential in the Biotech Sector

Zevra Therapeutics, Inc. (NASDAQ: ZVRA), a promising player in the biotechnology sector, has caught the attention of investors with its impressive potential upside and strategic focus..

Zymeworks Inc. (ZYME) Stock Analysis: Unraveling the 64.55% Upside Potential for Biotech Investors

Zymeworks Inc. (NASDAQ: ZYME) stands at a pivotal juncture in the biotechnology sector, presenting a substantial potential upside of 64.55% according to recent analyst ratings. With..

Ginkgo Bioworks Holdings, Inc. (DNA) Stock Analysis: Navigating the Biotech Terrain with Strategic Insights

Ginkgo Bioworks Holdings, Inc. (DNA), a pioneer in the biotechnology industry, is making waves with its innovative approach to cell programming. Headquartered in Boston, Massachusetts, Ginkgo..

Relay Therapeutics, Inc. (RLAY) Stock Analysis: Uncovering a Potential 311% Upside in Biotech Innovation

Relay Therapeutics, Inc. (NASDAQ: RLAY) stands at the forefront of biotechnology innovation, with its clinical-stage precision medicines targeting oncology and genetic diseases. Based in Cambridge, Massachusetts,..

LifeMD, Inc. (LFMD) Stock Analysis: A 48.8% Revenue Growth Story in Telehealth

LifeMD, Inc. (NASDAQ: LFMD) has positioned itself as a compelling player in the burgeoning telehealth sector, attracting attention with a robust revenue growth rate of 48.8%...

Claritev Corporation (CTEV) Stock Analysis: Navigating Turbulence with Strategic Data Analytics

Claritev Corporation (NASDAQ: CTEV), a key player in the healthcare sector’s dynamic landscape, primarily operates within the health information services industry. As a burgeoning entity headquartered..

Xeris Biopharma Holdings (XERS): Investor Outlook Reveals 42% Upside Potential

Xeris Biopharma Holdings, Inc. (NASDAQ: XERS) is catching the attention of investors with its promising growth trajectory and the potential for significant upside in its stock..

CureVac N.V. (CVAC) Investor Outlook: Analyzing Growth Potential Amidst a 5.91% Upside

CureVac N.V. (NASDAQ: CVAC), a pioneering entity in the biotechnology sector, is positioning itself as a formidable player in the mRNA technology space. Headquartered in Tübingen,..

Definitive Healthcare Corp. (DH) Stock Analysis: A Closer Look at a Potential 12.95% Upside

Definitive Healthcare Corp. (NASDAQ: DH), a prominent player in the healthcare information services sector, operates a robust software as a service (SaaS) platform. This platform provides..

InMode Ltd. (INMD) Stock Analysis: Healthcare Innovator with 21% Upside Potential

For investors on the lookout for promising opportunities in the healthcare sector, InMode Ltd. (NASDAQ: INMD) presents a compelling case. With a market capitalization of $888.09..

OrthoPediatrics Corp. (KIDS) Stock Analysis: Unveiling a 67.72% Potential Upside in the Medical Device Sector

OrthoPediatrics Corp. (NASDAQ: KIDS) is carving out a significant niche within the healthcare sector, specifically in the medical devices industry focused on pediatric orthopedic solutions. With..

AMN Healthcare Services Inc (AMN) Stock Analysis: Navigating the 22.74% Potential Upside

AMN Healthcare Services Inc (NYSE: AMN) stands as a key player in the healthcare sector, specifically within the medical care facilities industry. Headquartered in Dallas, Texas,..

Valneva SE (VALN) Investor Outlook: A 117% Potential Upside in Biotechnology

Valneva SE (VALN), a French biotechnology company specializing in prophylactic vaccines, is capturing the attention of investors with its promising financial outlook and substantial potential upside...

Stoke Therapeutics, Inc. (STOK) Stock Analysis: A Promising 89.3% Upside in the Biotech Sector

Stoke Therapeutics, Inc. (NASDAQ: STOK), a pioneering entity in the biotechnology industry, is capturing investor attention with a compelling potential upside of 89.3%. This early-stage biopharmaceutical..

Iovance Biotherapeutics, Inc. (IOVA) Stock Analysis: Unraveling a 363% Potential Upside in the Biotech Arena

Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) is making waves in the biotechnology sector, driven by its pioneering work in cell therapies aimed at treating metastatic melanoma and..

Eton Pharmaceuticals (ETON) Stock Analysis: A 104% Upside Potential with Robust Revenue Growth

Eton Pharmaceuticals, Inc. (NASDAQ: ETON) has emerged as a notable player in the healthcare sector, specifically within the niche of drug manufacturing for specialty and generic..

Butterfly Network, Inc. (BFLY) Stock Analysis: Navigating a 70% Potential Upside in the Medical Device Sector

Butterfly Network, Inc. (NYSE: BFLY) stands as a transformative player within the healthcare sector, specifically in the medical devices industry. Renowned for its innovative ultrasound imaging..

Praxis Precision Medicines, Inc (PRAX) Stock Analysis: Exploring a Remarkable 116.89% Potential Upside

Praxis Precision Medicines, Inc (NASDAQ: PRAX), a clinical-stage biopharmaceutical innovator, is capturing investor attention with its promising pipeline of therapies targeting central nervous system (CNS) disorders...

Neuropace, Inc. (NPCE) Stock Analysis: Unpacking a 52.49% Potential Upside in the Healthcare Sector

Investors with a keen eye on the healthcare sector should take note of Neuropace, Inc. (NASDAQ: NPCE), a promising player in the medical devices industry. With..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds